Rhamnose: chemical structure, biological roles, natural sources, applications, and safety
Definition
Rhamnose is a deoxy-hexose monosaccharide with the molecular formula C₆H₁₂O₅, belonging to the class of aldoses. It is one of the few naturally occurring sugars that exist primarily in the L-configuration (L-rhamnose), which is uncommon among biological monosaccharides.
Rhamnose is an organic chemical compound, a monosaccharide naturally occurring deoxy sugar, a methyl-pentose or a 6-deoxy-hexose. In nature, it appears in the form L- and is obtained chemically from sea buckthorn and algae belonging to the Bacillariophyceae family.
It is found in plants, bacteria, and algae, typically as a structural component of glycosides, plant polysaccharides, and bacterial cell wall glycoconjugates.
1. Chemical properties
Molecular formula: C₆H₁₂O₅
Molar mass: 164.16 g/mol
Structure:
six-carbon sugar with an aldehyde group at carbon 1
classified as 6-deoxy-L-mannose
exists in both linear and cyclic (pyranose or furanose) forms
Solubility: highly soluble in water
Physical state: white crystalline solid, mildly sweet in taste
2. Natural occurrence
3. Biological functions
In plants:
involved in secondary metabolites such as flavonoid glycosides
contributes to solubility, transport, and bioactivity of phenolic compounds
In bacteria:
structural component of cell wall antigens, important in immune recognition
contributes to bacterial adhesion, virulence, and biofilm stability
In humans:
not metabolized significantly
has negligible glycemic impact
partially absorbed, with excess excreted in urine
4. Applications
Cosmetics
Flavoring agent. The purpose of this ingredient is to modify the solution to add flavour. Natural flavouring extracts are rather expensive, so the cosmetic and pharmaceutical industries resort to synthesised substances that have sensory characteristics mostly similar to natural flavourings or are naturally equivalent. This ingredient is isolated through chemical processes or is synthesised from chemicals.
CAS: 10030-85-0, 3615-41-6
Nutraceuticals and food
Present in plant extracts rich in polyphenols
Contributes indirectly to antioxidant and anti-inflammatory effects through glycosylated flavonoids
Used in fiber complexes and functional food ingredients
Pharmaceuticals and microbiology
Used as a substrate in bacterial identification assays
Incorporated in vaccine development, especially for conjugates targeting bacterial LPS
Aids in the structural analysis of complex glycans
5. Safety and tolerability
Considered safe for human consumption
Naturally present in many plant-based foods and herbal extracts
Non-toxic and non-allergenic
Only partially absorbed, well tolerated
High doses may cause mild digestive effects (e.g., gas, loose stools) due to fermentation in the colon
6. Conclusion
Rhamnose is a naturally occurring deoxy sugar with important roles in plant biochemistry, bacterial surface structures, and flavonoid metabolism. It is well tolerated and increasingly valued in cosmetics for skin repair and in nutraceuticals as part of bioactive glycosides.
Its unique L-configuration, plant origin, and functional versatility make it a key ingredient in innovative health and skincare formulations.
Synonyms:
L(+)-Rhamnose Monohydrate, l-(+)-Rhamnose monohydrate, (2R,3R,4S,5S)-2,3,4,5-Tetrahydroxyhexanal hydrate, rhamnose monohydrate, Rhamnose
References__________________________________________________________________________
Novotná R, Škařupová D, Hanyk J, Ulrichová J, Křen V, Bojarová P, Brodsky K, Vostálová J, Franková J. Hesperidin, Hesperetin, Rutinose, and Rhamnose Act as Skin Anti-Aging Agents. Molecules. 2023 Feb 11;28(4):1728. doi: 10.3390/molecules28041728.
Abstract. Aging is a complex physiological process that can be accelerated by chemical (high blood glucose levels) or physical (solar exposure) factors. It is accompanied by the accumulation of altered molecules in the human body. The accumulation of oxidatively modified and glycated proteins is associated with inflammation and the progression of chronic diseases (aging). The use of antiglycating agents is one of the recent approaches in the preventive strategy of aging and natural compounds seem to be promising candidates. Our study focused on the anti-aging effect of the flavonoid hesperetin, its glycoside hesperidin and its carbohydrate moieties rutinose and rhamnose on young and physiologically aged normal human dermal fibroblasts (NHDFs). The anti-aging activity of the test compounds was evaluated by measuring matrix metalloproteinases (MMPs) and inflammatory interleukins by ELISA. The modulation of elastase, hyaluronidase, and collagenase activity by the tested substances was evaluated spectrophotometrically by tube tests. Rutinose and rhamnose inhibited the activity of pure elastase, hyaluronidase, and collagenase. Hesperidin and hesperetin inhibited elastase and hyaluronidase activity. In skin aging models, MMP-1 and MMP-2 levels were reduced after application of all tested substances. Collagen I production was increased after the application of rhamnose and rutinose.
Chen W, Gu L, Zhang W, Motari E, Cai L, Styslinger TJ, Wang PG. L-rhamnose antigen: a promising alternative to α-gal for cancer immunotherapies. ACS Chem Biol. 2011 Feb 18;6(2):185-91. doi: 10.1021/cb100318z.
Abstract. The targeting of autologous vaccines toward antigen presenting cells (APCs) via the in vivo complexation between anti α-Gal (anti-Gal) antibodies and α-Gal antigens presents a promising cancer immunotherapy with enhanced immunogenicity. This strategy takes advantage of the ubiquitous anti-Gal antibody in human serum. In contrast to the α-Gal epitope, the recent identification of high titers of anti-l-rhamnose (anti-Rha) antibodies in humans reveals a new approach toward immunotherapy employing l-rhamnose (Rha) monosaccharides. In order to evaluate this simple antigen in preclinical applications, we have synthesized Rha-conjugated immunogens and successfully induced high titers of anti-Rha antibodies in wildtype mice. Moreover, our studies demonstrate for the first time that wildtype mice could replace α1,3galactosyltransferase knockout (α1,3GT KO) mice in such antigen/antibody-mediated vaccine design when developing cancer immunotherapies.
Lang S, Wullbrandt D. Rhamnose lipids--biosynthesis, microbial production and application potential. Appl Microbiol Biotechnol. 1999 Jan;51(1):22-32. doi: 10.1007/s002530051358.
Abstract. Biosurfactants containing rhamnose and beta-hydroxydecanoic acid and called rhamnolipids are reviewed with respect to microbial producers, their physiological role, biosynthesis and genetics, and especially their microbial overproduction, physicochemical properties and potential applications. With Pseudomonas species, more than 100 g l-1 rhamnolipids were produced from 160 g l-1 soybean oil at a volumetric productivity of 0.4 g l-1 h-1. The individual rhamnolipids are able to lower the surface tension of water from 72 mN m-1 to 25-30 mN m-1 at concentrations of 10-200 mg l-1. After initial testing, rhamnolipids seem to have potential applications in combating marine oil pollution, removing oil from sand and in combating zoosporic phytopathogens. Rhamnolipids are also a source of L-rhamnose, which is already used for the industrial production of high-quality flavor components.
Giraud MF, Naismith JH. The rhamnose pathway. Curr Opin Struct Biol. 2000 Dec;10(6):687-96. doi: 10.1016/s0959-440x(00)00145-7.
Abstract. L-Rhamnose is a deoxy sugar found widely in bacteria and plants. Evidence continues to emerge about its essential role in many pathogenic bacteria. The crystal structures of two of the four enzymes involved in its biosynthetic pathway have been reported and the other two have been submitted for publication. This pathway does not exist in humans, making enzymes of this pathway very attractive targets for therapeutic intervention.
Smith TN, Oppenheimer SB. Involvement of L(-)-rhamnose in sea urchin gastrulation: a live embryo assay. Zygote. 2015 Apr;23(2):222-8. doi: 10.1017/S0967199413000452.
Abstract. The sea urchin embryo is a National Institutes of Health model system that has provided major developments, and is important in human health and disease. To obtain initial insights to identify glycans that mediate cellular interactions, Lytechinus pictus sea urchin embryos were incubated at 24 or 30 h post-fertilization with 0.0009-0.03 M alpha-cyclodextrin, melibiose, L(-)-rhamnose, trehalose, D(+)-xylose or L(-)-xylose in lower-calcium artificial sea water (pH 8.0, 15°C), which speeds the entry of molecules into the interior of the embryos. While α-cyclodextrin killed the embryos, and L(-)-xylose had small effects at one concentration tested, L(-)-rhamnose caused substantially increased numbers of unattached archenterons and exogastrulated embryos at low glycan concentrations after 18-24 h incubation with the sugar. The results were statistically significant compared with the control embryos in the absence of sugar (P < 0.05). The other sugars (melibiose, trehalose, D(+)-xylose) had no statistically significant effects whatsoever at any of the concentrations tested. In total, in the current study, 39,369 embryos were examined. This study is the first demonstration that uses a live embryo assay for a likely role for L(-)-rhamnose in sea urchin gastrula cellular interactions, which have interested investigators for over a century.
Malagon I, Onkenhout W, Klok M, van der Poel PF, Bovill JG, Hazekamp MG. Rhamnose and rhamnitol in dual sugar permeability tests. J Pediatr Gastroenterol Nutr. 2006 Aug;43(2):265-6. doi: 10.1097/01.mpg.0000226379.41365.62.
Abstract. Rhamnose is one of the sugars regularly used to conduct the dual sugar permeability test. For more than 30 years, it has been assumed that rhamnose is an inert sugar not metabolized by the human body and only fermented by some colonic bacteria into rhamnulose. While conducting an investigation on gut permeability in children undergoing cardiac surgery, increased concentrations of rhamnitol were found in the urine samples. The present report suggests that rhamnose is not an inert sugar and it is partially metabolized into rhamnitol by the human body.
Gasparini F, Franchi N, Spolaore B, Ballarin L. Novel rhamnose-binding lectins from the colonial ascidian Botryllus schlosseri. Dev Comp Immunol. 2008;32(10):1177-91. doi: 10.1016/j.dci.2008.03.006.
Abstract. In a full-length cDNA library from the compound ascidian Botryllus schlosseri, we identified, by BLAST search against UniProt database, five transcripts, each with complete coding sequence, homologous to known rhamnose-binding lectins (RBLs). Comparisons of the predicted amino acid sequences suggest that they represent different isoforms of a novel RBL, called BsRBL-1-5. Four of these isolectins were found in Botryllus homogenate after purification by affinity chromatography on acid-treated Sepharose, analysis by reverse-phase HPLC and mass spectrometry. Analysis of both molecular masses and tryptic digests of BsRBLs indicated that the N-terminal sequence of the purified proteins starts from residue 22 of the putative amino acid sequence, and residues 1-21 represent a signal peptide. Analysis by mass spectrometry of V8-protease digests confirmed the presence and alignments of the eight cysteines involved in the disulphide bridges that characterise RBLs. Functional studies proved the enhancing effect on phagocytosis of the affinity-purified material. Results are discussed in terms of phylogenetic relationships of BsRBLs with orthologous molecules from protostomes and deuterostomes.
Rhamnose 
